BioHarvest Sciences Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 3 Fair Values set on narratives written by author
BHST Community Narratives
Plant Based CDMO Expansion And Health Pros Network Will Drive Long Term Upside
CDMO Pipeline And Hydration Expansion Will Transform Long Term Earnings Power
CDMO Pipeline And Capacity Expansion Will Face Setbacks Yet Ultimately Support Future Earnings
Plant Based CDMO Expansion And Health Pros Network Will Drive Long Term Upside
View narrativeCDMO Pipeline And Capacity Expansion Will Face Setbacks Yet Ultimately Support Future Earnings
View narrativeCDMO Pipeline And Hydration Expansion Will Transform Long Term Earnings Power
View narrativeTrending Discussion
No trending discussion available.
Recently Updated Narratives
BHST: CDMO Contract Shift Will Drive Long-Term Revenue From 2027
BHST: Data Science Grant Will Support Future R&D Productivity Upside
CDMO Pipeline And Hydration Expansion Will Transform Long Term Earnings Power
Snowflake Analysis
BioHarvest Sciences Inc. Key Details
- -0.49
- 58.95%
- -31.21%
- 13.5%
About BHST
- Founded
- n/a
- Employees
- 89
- CEO
- Website
View website
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company has a strategic collaboration with Tate & Lyle plc for the development of plant-based sweetener molecules. The company is based in Vancouver, Canada.